• CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources

     

  • 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsGAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    Rescheduled, so you won't miss a thing! Find out what to do next!

    April 20-24, 2021, Honolulu, Hawaii

    More Information

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations! (EXTENDED DEADLINE)

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2020-21 National Board of Directors? Register online NOW by March 31, 2020!

    Step Up - NOW is the Time! Register Here>

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2020.

    Get started... nominate today!

Risks High for Elderly Patients Receiving Angioplasty to Fix Narrowed Heart Artery

Elderly patients represent 72.6 percent of patients who receive the percutaneous coronary intervention treatment for unprotected left main coronary artery stenosis (ULMCA) stenosis.

Trend data, however, indicate the use of this procedure is slowly increasing, and is being used more often for lower-urgency procedures.

Poor health outcomes in elderly ULMCA patients are common and are likely influenced by both patient and procedural factors, including the type of stent used.

The study showed 40% of elderly patients die within the first 3 years of followup after the procedure.

Researchers concluded that clinical trials are needed to examine the safety and effectiveness of angioplasty in patients with ULMCA disease, with attention to best practices and the generalizability of trial populations.

More details are in Brennan et al. (2012). Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States. Journal of the American College of Cardiology, 59(7), 648-654.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: